Terms: = Breast cancer AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH AND Clinical Outcome
3 results:
1. Identification of subgroups along the glycolysis-cholesterol synthesis axis and the development of an associated prognostic risk model.
Zhang E; Chen Y; Bao S; Hou X; Hu J; Mu OYN; Song Y; Shan L
Hum Genomics; 2021 Aug; 15(1):53. PubMed ID: 34384498
[TBL] [Abstract] [Full Text] [Related]
2. clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes.
De Talhouet S; Peron J; Vuilleumier A; Friedlaender A; Viassolo V; Ayme A; Bodmer A; Treilleux I; Lang N; Tille JC; Chappuis PO; Buisson A; Giraud S; Lasset C; Bonadona V; Trédan O; Labidi-Galy SI
Sci Rep; 2020 Apr; 10(1):7073. PubMed ID: 32341426
[TBL] [Abstract] [Full Text] [Related]
3. Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy.
Karlsson P; Cole BF; Colleoni M; Roncadin M; Chua BH; Murray E; Price KN; Castiglione-Gertsch M; Goldhirsch A; Gruber G;
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):398-402. PubMed ID: 20729007
[TBL] [Abstract] [Full Text] [Related]
